Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

QGEN

Qiagen NV (QGEN)

Qiagen NV
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:QGEN
DateTimeSourceHeadlineSymbolCompany
06/13/20244:05PMGlobeNewswire Inc.QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labsNYSE:QGENQiagen NV
06/12/20244:05PMGlobeNewswire Inc.QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growthNYSE:QGENQiagen NV
06/11/20244:05PMGlobeNewswire Inc.QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillanceNYSE:QGENQiagen NV
06/06/20244:50PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:QGENQiagen NV
06/06/20244:05PMGlobeNewswire Inc.QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition periodNYSE:QGENQiagen NV
06/05/20244:05PMGlobeNewswire Inc.QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobeNYSE:QGENQiagen NV
06/03/20242:00AMGlobeNewswire Inc.QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal careNYSE:QGENQiagen NV
05/31/20244:42PMEdgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:QGENQiagen NV
05/30/20245:55PMGlobeNewswire Inc.QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applicationsNYSE:QGENQiagen NV
05/30/20244:45PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:QGENQiagen NV
05/30/20244:05PMGlobeNewswire Inc.QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applicationsNYSE:QGENQiagen NV
05/29/20244:05PMGlobeNewswire Inc.QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicineNYSE:QGENQiagen NV
05/14/20244:05PMGlobeNewswire Inc.QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision supportNYSE:QGENQiagen NV
05/13/20242:00AMGlobeNewswire Inc.QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate resultsNYSE:QGENQiagen NV
05/07/20244:05PMGlobeNewswire Inc.QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensicsNYSE:QGENQiagen NV
05/02/20244:05PMGlobeNewswire Inc.QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applicationsNYSE:QGENQiagen NV
04/29/20244:05PMGlobeNewswire Inc.QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidanceNYSE:QGENQiagen NV
04/24/20244:05PMGlobeNewswire Inc.QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistanceNYSE:QGENQiagen NV
04/09/20249:48AMGlobeNewswire Inc.QIAGEN N.V. to release results for Q1 2024 and hold webcastNYSE:QGENQiagen NV
04/03/20244:05PMGlobeNewswire Inc.QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024NYSE:QGENQiagen NV
03/25/20244:05PMGlobeNewswire Inc.QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare systemNYSE:QGENQiagen NV
03/18/20244:05PMGlobeNewswire Inc.QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirementsNYSE:QGENQiagen NV
03/11/20245:59AMGlobeNewswire Inc.QIAGEN announces Form 20-F annual report filing for 2023 resultsNYSE:QGENQiagen NV
02/27/20245:44PMGlobeNewswire Inc.QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discoveryNYSE:QGENQiagen NV
02/27/20244:05PMGlobeNewswire Inc.QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certificationNYSE:QGENQiagen NV
02/15/20244:05PMGlobeNewswire Inc.QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certificationNYSE:QGENQiagen NV
02/08/20249:47AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:QGENQiagen NV
02/06/20244:05PMGlobeNewswire Inc.QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitabilityNYSE:QGENQiagen NV
01/25/202410:00AMGlobeNewswire Inc.QIAGEN announces partnership with Penn State University to advance microbiome sciencesNYSE:QGENQiagen NV
01/23/20244:13PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:QGENQiagen NV
 Showing the most relevant articles for your search:NYSE:QGEN

Your Recent History

Delayed Upgrade Clock